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Injection of antibody into previously immunized animals can specifically suppress 
the expected antibody response (1-4). This finding led to the suggestion that serum 
antibody might act as a  "feedback" type of mechanism. Experiments  of this  type, 
however, are not physiological in the sense  that the serum antibody concentration of 
the immunized animal is raised to a higher level than normally present at that stage 
of immunization,  and  the passively  administered  antibody,  usually  obtained  from 
well immunized animals, is probably of average higher binding affinity than the anti- 
body  in  the  recipient  immunized  animal.  The  question  remains,  therefore,  as  to 
whether the antibody molecules in the immunized animal are of sufficient concentra- 
tion and binding affinity to regulate antibody formation in that animal. 
One approach to answering this question is to remove antibody specifically from 
immunized animals and then to determine if the rate of antibody formation changes. 
It is well recognized by immunologists, that hyperirnmunized animals can be bled 
repeatedly and that serum antibody levels are mainta~ed without further administra- 
tion of antigen, suggesting an increased rate of synthesis. In addition, repeated plasma- 
pheresis in humans has been shown to stimulate elevation of serum antibody levels to 
antigens injected many months previously (5, 6).  Such experiments in which a large 
proportion of plasma is removed may induce profound nonspecific effects,  for example, 
by reducing the concentration of immunoglobul~n or other factors in the circulation. 
The critical point experimentally  is  to remove antibody of one specificity only and 
thus affect formation of antibody to that specificity only. Under such circumstances, 
interpretations  can be made regarding the immunogenicity of the specific  persisting 
antigen. This type of experiment can be accomplished by removing large samples of 
plasma  from immunized animals  repeatedly,  exposing the plasma to antigen  cova- 
lently bound to a particulate material, and returning the treated plasma without the 
immunoadsorbent to the animal. 
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The present experiments describe such specific removal of a  large portion of 
serum  antibody  from immunized  rabbits  and  the  effect of this  removal upon 
antibody  formation.  The results  suggest  that  serum  antibody  acts  as a  major 
regulatory mechanism for antibody formation to metabolizable antigens. 
Materials and Methods 
Antigens and Antibodies.--Bovine  serum albumin (BSA)  x, 4X recrystallized was obtained 
from Nutritional Biochemicals Corp., Freehold, N.J.  (Lot No. 1359). Bacteriophage Tz (T2) 
was prepared by the method of Adams (7). The BSA used gave a single line of precipitation 
on immunoelectrophoresis with rabbit anti-bovine serum. Human 7S gamma globulin (HGG) 
(Nutritional Biochemicals Corp.) gave a single line of precipitation on immunodectrophoresis 
with rabbit anti-human serum. 
Rabbit antibody to BSA contained 9.6 mg antibody protein/ml and gave a single line of 
precipitation  on  immunoelectrophoresis with  bovine serum.  Goat  antibody  to  HGG con- 
tained 8.6 mg antibody protein/ml and rabbit antibody to q~X had a neutralizing titer of K  = 
27O0. 
Immunization  and Antibody Assays.--For  passive immunization,  albino rabbits,  3-4 kg, 
were injected intravenously with 16 mg of rabbit antibody to BSA and 0.2 ml of rabbit anti- 
~X (K =  2700), For active immunization, rabbits were injected intravenously with 10 mg/kg 
of BSA and 1-4 X  101°  T2 in saline. 
Serum anti-BSA titers were measured by the Farr technique (8)  using 0.4 #g antigen N 
and an ABC precipitating line of 33%. Serum anti-T¢ titers were determined by the phage 
neutralization  test  (7). 
Preparation of BAC-BSA.--Bromoacetyl cellulose (BAC) was prepared  according to the 
method of Robbins et ai. (9). In addition, two lots (Nos. 218 and 231) were purchased from 
Miles Laboratories,  Inc.,  Elkhart,  Ind. 
a~sI-BSA was prepared according to the method of Greenwood et al. (10). 96--99% of the 
counts of each preparation were precipitated by 5% trichloroacetic acid or by specific anti- 
body. 
In order to quantify the amount of BSA bound to BAC, 600 mg of BSA and 0.1 mg 125I- 
BSA (10 s counts/#g) were incorporated into BAC as previously described (11). The amount of 
radioactivity of all the washes, as well as the radioactivity remaining on the washed adsorbent, 
were measured so that the amount of BSA covalently bound to the BAC could be calculated 
by either method. Assuming that 125I-BSA and BSA are equally bound to BAC during the 
coupling procedure, it was found that 54-55% of the BSA was covaienfly bound to BAC in 
the preparations used. The BAC-BSA was exhaustively washed with 0.15 M phosphate buffer 
pH 7.4 until the number of nondialyzable counts was at background level. 
It was also found that an amount of immunoadsorbent containing 13 mg of BSA bound 4.1 
mg of anti-BSA. 90% of the adsorbed anti-BSA was recovered after incubation of BAC-BSA 
with 0.1 N acetic acid, stirring at 37°C for 1 hr, and dialysis against 0.1 ~  sodium chloride- 
0.1 ~ phosphate buffer pH 7.4 overnight. In addition, it was found that the antibody-combin- 
ing capacity of the BAC-BSA was fully regenerated by this procedure. 
Cannulation of Rabbits.--Animals  were  anesthetized  with  nembutal  and  also  received 
atropine 0.04 mg/kg and aqueous heparin 10 mg/kg intravenously. The femoral artery and 
vein were cannulated and a 35-40 cc sample of blood was withdrawn from the femoral artery. 
1  Abbreviations used in this paper: BAC, bromacetyl cellulose; BSA, bovine serum albumin; 
HGG, human gamma globulin; I"2, bacteriophage T~; TLCK, p-toluenesulfonyl lysine chloro- 
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The plasma was separated from the red cells by centrifugation at 6000  g for 5  rain. The 
plasma was then incubated with portions of BAC-BSA for 15 rain at 37°C, occasionally  stirred, 
and then centrifuged at 105,000 g for 20 mln to remove the immunoadsorbent. The adsorbed 
plasma and red cells were mixed and returned to the rabbit through the femoral vein. This 
entire maneuver, i.e., removal, adsorption, and replacement of blood, was repeated 4-5 times 
per animal over a period of 4-6 hr. The rabbits were given 1 ml of Wycillin-SM immediately 
after surgery and 4 days later. They were kept anti-coagulated with intramuscular injections 
of Coumadin for 1 wk after surgery. 
Gel F~ra~z~.---Sephadex G-200 was swelled in distilled water and equih~rated with 0.1 
M  phosphate buffer, pH 7.2. The outside and inside volumes were determined by using dextran 
blue 2000 and phenol red. BSA, rabbit 7S gsmma globulin, and horse cytochrome c were used 
as markers. 
Radioaclire Cou~ng.~Radioactive samples were counted in a New England Nuclear deep 
well counter to the 95% confidence level. 
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F~G. 1. Serum antibody  levels to BSA and ~X in a passively immunized rabbit in which 
anti-BSA  was removed. Rabbit was injected intravenously with 15 mg of rabbit anti-BSA and 
0.2 ml of rabbit anti-~#X (K =  2700) 24 hr before removal of anti-BSA. 
RESULTS 
Antibody Reraoval  from Passively Immunized Rabbits.--In order to determine 
whether serum antibody can be eCficienfly and specifically removed from im- 
munized animals, 3 rabbits were injected intravenously with 16 mg of anti-BSA 
and with 0.2 ml of anti-~X (K of 2700). The following day, cannulation for re- 
moval of antibody was carried out. The rabbits were bled at frequent intervals 
during and after the procedure, and anti-BSA and anti-qbX titers were measured. 
Fig. 1 shows the antibody titers during the removal procedure in a representa- 
tive animal. As can be seen, approximately 80% of serum antibody to BSA was 
removed after six bleedings and incubations with  BAC-BSA during a  4.5  hr 
period without  detectable effect on  the serum  antibody levels to ~X.  Serum 
anti-BSA tlters 2 days after cannulation were equal to or lower than immediate 
postoperative levels. Similar results were obtained in two  additional animals. 1178  REGIJLATION  0]?  ANTIBODY  FORMATION.  I 
This experiment shows that the majority of antibody activity can be removed 
specifically in passively immunized animals. 
Antibody  Removal from Actively Immunized Rabbits.--The  above  technique 
was applied to actively imnatmized animals in order to determine  the effect  of 
removal of antibody to BSA on anti-BSA formation. 
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FIO. 2. Serum antibody levels to BSA and T2 in actively immunized rabbits in which anti- 
BSA was removed. Rabbits were injected intravenously with 10 mg/kg of BSA and 2 X  10  ~° 
"1"2 in saline. A: Average serum antibody levels in seven control immunized animals. B and C: 
two representative animals in which anti-BSA was removed. 
For this purpose,  six rabbits were injected  intravenously  with  10 mg/kg of 
BSA and 1-4 X  10  t° 1"2 phage in saline. The anti-BSA levels in the sera of such 
animals reached a  peak titer within  2 wk after antigen injection.  The animals 
were cannulated  on days 16-20 when serum anti-BSA levels were falling,  indi- 
cating  that rate of synthesis had slowed. Antibody titers to BSA and T, were 
measured at frequent intervals before and after cannulation. MARTIN  W.  GRA]? AND  JONATHAN  W.  UHR  1179 
Fig. 2 shows the average serum antibody levels to BSA and T2 in seven con- 
trol immunized animals and antibody levels in two representative animals in 
which antibody to BSA was removed. As can be seen in 2a, both anti-BSA and 
anti-T~ peak titers were reached by 2 wk. Thereafter, anti-BSA levels declined 
steadily, and anti-T~ remained at a plateau. In the cannulated animals, between 
38% and 43% of the antibody to BSA was removed by the experimental pro- 
cedure (2b, c). Anti-BSA levels continued to fall for 1-2 days after cannulation. 
At this point anti-BSA levels began to rise and reached peak levels usually 5 days 
later. Anti-T2 levels in the cannulated animals were unaffected by the adsorp- 
tion procedure and were similar to those seen in the control immunized animals. 
Table I shows the results in tabular form for the two rabbits illustrated in the 
TABLE I 
Serum Antibody Ti~ers in Rabbi~s Immunized  with BSA crut Bacteriophage T~ in Which Anti- 
BSA Has Been Remaved 
Serum antibody titers 
Rabbit No.*  Precannulation~  Postremoval  Peak of rebound 
Anti-BSA§  Anti-TiR  Anti-BSA  Anti-Ts  Anti-BSA  Anti-TI 
1-25  120  16.4  48  13.5  75  11.2 
1-26  86  12.4  54  12.0  74  7.6 
1-28  20  7.4  14  8.2  17  6.2 
1-31  97  37  36  36  65  38 
1-32  42  35  16  35  28  35 
1-33  21  6.1  12  6.2  16  5.8 
* Rabbits were injected with 10 mg/kg BSA and 1-4 X 10  t° T~.in  saline intravenously. 
~: 16-20 days after immunization, antibody to BSA was removed. 
§ #g BSA bound/m1. 
II Neutralizing titer (K). 
preceding Fig. and four additional animals. As can be seen, in all animals there 
was a significant removal of serum antibody to BSA followed by a pronounced 
rise in serum antibody levels above postoperative levels reaching peak values 
usually 5 days after cannulation. Antibody levels to T2 were not affected. 
Antibody adsorbed by the BAC-BSA was eluted with acetic acid and dialyzed 
as previously described. Some of the material precipitated during dialysis. The 
amount of anti-BSA in the supernatant, as determined by the Farr technique, 
accounted for 30-73 %  of the faU in serum antibody titer during the removal 
procedure in the six animals (a plasma volume of 30 ml/kg was assumed for 
each rabbit). In contrast, three of six eluates did not show detectable antibody 
to T~; three had trace amounts (K's less than 0.8). These results are consistent, 
therefore, with the specificity of removal of antibody to BSA. 
We interpret the subsequent rise of anti-BSA levels in the experimental ani- 
mals as caused by an increase in the rate of antibody formation to BSA. We ex- 1180  REGULATION  OF  ANTIBODY  FORMATION.  I 
clude a change in the rate of catabolism of immunoglobulin in such animals, a 
priori, an unlikely possibility, because anti-T~ levels were similar in the control 
and cannulated animals. Redistribution of anti-BSA between extra- and intra- 
vascular compartments cannot account for this considerable elevation in titer 
because no such change in titers was seen in the passively immunized animals 
and,  furthermore, in four of the six actively immunized cannulated  animals, 
there was a continued fall in serum antibody levels for 24-48 hr before the rise 
in serum antibody level began. 
Release of BSA from BAC-BSA.--The next and  obvious question  to arise 
was whether this stimulation of antibody formation was caused by antigen re- 
leased from the immunoadsorbent into the circulation of the animals. In the 
TABLE II 
Radioaclivily in Plasma Pregrealed  with B  A C-BS  A 
Radioactivity in adsorbed plasma 
Rabbit No.  Maximal BSA 
Postdialysis*  Coprecipitated by  Coprecipitsted  by  pra~nt~ 
BSA--anti-BSA  H~ti-HGG 
cpm  cpm  cpm  ~g 
1-25  2890  680  --§  2.7 
1-26  2278  612  --  3.2 
1-28  379.5  799  --  4.4 
1-31  1564  646  646  3.3 
1-32  1700  680  646  3.7 
1-33  1632  663  680  3.5 
* Adsorbed plasma samples were dialyzed against 0.1 ~ sodium chloride-0.1 M  phosphate 
buffer, pH 7.4, overnight. The total, radioactivity returned to each animal is shown. 
Calculated from cpm coprecipitated by BSA-anti-BSA. 
§ w, not done. 
preceding experiments, the BSA had been iodinated with 12sI before binding to 
the BAC. Portions of the treated plasma samples which had been returned to 
the immunized rabbits were saved and tested for the presence of antigen re- 
leased from the immunoadsorbent. 
Table II shows the maximal amount of radioactive material returned to each 
animal and its specific coprecipitability. Table HI shows  two representative 
experiments in which  the adsorbed plasma was treated with either 100/~g of 
BSA or HGG, and an excess of specific antiserum. As can be seen from the two 
tables,  extremely  minute  amounts  of  radioactivity  were  released  from  the 
jmmunoadsorbent. If all the radioactivity that coprecipitated with BSA-anti- 
BSA  represented  BSA  (10 cpm above background/ml plasma),  the maximal 
amount that could have been administered to each animal ranged from 2.7 to 
4.4 #g. However, an equal amount of radioactivity was coprecipitated with an 
immunologically, unrelated  antigen-antibody precipitate.  The BSA-anti-BSA MARTIN W.  GRAF  AND JONATHAN W.  UkLK  1181 
precipitate, under the same conditions as above, coprecipitated 97 %  of ~*6I- 
BSA, whereas HGG-anti-HGG coprecipitated only 4 %. Thus, no evidence was 
obtained that this released material is antigen. 
The  immunogenicity  of  the  plasma  released  material  was  investigated. 
BAC-BSA was incubated with fresh normal plasma, and release of radioactivity 
equivalent to that  in  the  above experiments was  achieved. This amount  of 
plasma was then injected into each of four BSA-primed rabbits. In this experi- 
ment, the injection of plasma was performed 4-8 days later than the  time of 
cannulation in the earlier experiments in order to allow serum antibody levels 
to fall further and, therefore, to more closely approximate those observed in the 
immunized animals after removal of antibody. Additional BSA-primed rabbits 
TABLE III 
Immunoprecipila~ion of Radioc~tive Plasma 
Radioactivity of adsorbed plasma 
Plasma No.  Antigen and antibody*  After addition of antigen  Mter addition of BSA and 
and antibody  anti-BSA to supernatsnt* 
Precipitate  Supernstant  Precipitate  Supematant 
cpm  cpm  cpm  cpm 
1-31  BSA and anti-BSA  9  11  --§  -- 
HGG and anti-HGG  10  10  1  8 
1-32  BSA and anti-BSA  10  12  --  -- 
HGG and anti-HGG  9  10  1  9 
* 100 gg of antigen and 0.5 ml of specific  antiserum were incubated with I ml of aAsorhed 
plasma at 37°C for I hr and 4°C for 18-24 hr. The precipitates were  washed twice with cold 
saline. 
§ --, not done. 
were injected with an amount  of BAC-BSA equivalent to the plasma released 
radioactivity or with BSA. 
Fig. 3 illustrates the responses of individual animals. As can be seen,  there 
was no detectable response of primed animals to treated plasma, the immuno- 
adsorbent itself, or BSA in amounts less than, or equal to, 20 #g. Indeed, with 
100 #g of BSA only one of two animals showed a booster response. 
It should be emphasized that an optimal control is an animal similarly im- 
munized but without the usual concentration and quality of serum antibody. 
Thus,  it  can  be  argued  that  immunized,  antibody-depleted  animals  have 
antibody of very low average binding affinity and are, therefore, much more 
susceptible to exogenous antigen than conventionally immunized animals. 
Regardless, these experiments provide no evidence that  immunogenic mate- 
rial released into plasma by the immunoadsorbent accounts for the antibody 
response after antibody removal. 1182  REGULATION  OF ANTIBODY  ]~OP,  MATION.  I 
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FIG. 3. Immunoge~icity of plasma adsorbed with BAC-BSA  or BSA in premed rabbits. 
Serum  antibody levels  to  BSA  of individual  animals ate  shown. Animals received  30  rag 
BSA intravenously and except for controls were challenged 24 days later with the indicated 
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The  physico-chemical characteristics  of  the  radioactive material  released 
into adsorbed plasma  was investigated by gel filtration on Sephadex G-200. 
Unlabeled  BSA,  rabbit  7S  gamma  globulin,  and  horse  cytochrome c  were 
added as markers. As can be seen in Fig. 4, there is little or no radioactivity 
associated with the BSA peak. 
Additional experiments revealed that the release of trace amounts of radio- 
activity from BAC-BSA into fresh plasma occurred within 1 rain, was not in- 
creased by incubation for an additional hr, was independent of  temperature 
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Fro. 4. Gel filtration on Sephadex G-200 of plasma previously adsorbed with tz6I-BSA- 
BAC. BSA, rabbit 7S gamma globulin and horse cytochrome c were used as markers. Eluting 
solvent was 0.1 M  phosphate buffer pH 7.2. 
(0°-37°C), and was not diminished by repeated exposure to plasma. It occurred 
in plasma previously heated to 80°C for 3 min and was not inhibited by TLCK, 
2  mg/ml  (p-toluenesulfonyl lysine chloromethyl ketone),  a  potent  inhibitor 
d  proteolytic enzymes (12). The released radioactivity was not extractable by 
chloroform. Nondialyzable  counts  were  not  released  into  physiological  salt 
solutions, but were released into 60 % sucrose. 
These studies, thus, have not elucidated the nature of the radioactive mate- 
rial or the mechanism d  its release. They suggest, however, that the release is 
not mediated by an enzymatic process, and that the radioactivity is not asso- 
dated with lipids.  The physico-chemical data are consistent with  the possi- 
bility that the released radioactivity is BSA bound to fragments of cellulose or 
aggregated BSA, although no support for this was obtained from immunopre- 
cipitation or immunization experiments. 1184  I~GULATION  OF  ANTIBODY  FORMATION.  I 
DISCUSSION 
A major problem in the evaluation of antibody-induced suppression has been 
to determine whether or not this mechanism operates during the normal im- 
mune response. 
The only experiment to our knowledge which indicates that this mechanism is 
a physiological one is the demonstration by Britton and MSUer (13), that injec- 
tion of Esckerichia coli lipopolysaccharide into mice results in a cyclical varia- 
tion in serum antibody levels and the number of antibody-forming cells in the 
spleen.  They suggest that the metabolism of serum antibody and the lack of 
metabolism of the antigen are responsible for the cyclical nature of this type of 
immune response. Their experiment shows, therefore, that serum antibody is a 
major regulatory mechanism for nonmetabolizable antigens. 
We interpret the present experiments as indicating that serum antibody also 
acts  as  a  regulatory mechanism  in  the  conventional  antibody  response  to 
metabolizable antigens.  Thus,  in  all six actively immunized  rabbits  studied 
after removal of a  large portion of serum antibody, there was a  pronounced 
rise in serum antibody levels beginning 1-2 days later, and reaching peak titers 
usually at 5 days. 
The obvious possibility, that the secondary response was caused by injection 
of antigen released from the immunoadsorbent,  did not receive support from 
several lines  of evidence: (a) A  minute proportion of I~SI-BSA-BAC was re- 
leased into plasma,  less  than  one part in 7  X  105. (b) Immunoprecipitation 
studies revealed that about half of the minute number of nondialyzable counts 
(approximately 20 cpm  above background  per ml  of adsorbed plasma)  was 
coprecipitated with either BSA or HGG and their specific antibodies.  (c) The 
same amount of material released into plasma by BAC-BSA or an equivalent 
amount of immunoadsorbent was not immunogenic for primed animals  with 
serum antibody titers approximating those of the actively immunized animals 
after antibody removal. Indeed,  100/~g of "free" BSA was required to stimu- 
late a response in one of two primed animals.  (d) The plasma-released radio- 
activity did not elute with BSA on gel filtration through Sephadex G-200. 
We therefore interpret  the increased  rate  of antibody formation  in  these 
experiments as resulting from persisting antigen which is rendered more im- 
munogenic after the removal of serum antibody. The mechanism by which this 
change in immunogenicity occurs is not known. The specificity of suppression 
indicates that serum antibody interacts with persisting immunogen. There is a 
potential  for  chemical  reaction,  therefore,  between  persisting  immunogen, 
circulating  antibody, and  antibody receptors on preantibody secreting cells; 
this reaction may not be in equilibrium.  Regarding the immunized rabbits in 
the present  experiments,  after injection  of approximately 30 mg of BSA in 
saline  intravenously  3  wk previously,  only minute  amounts  of undegraded, 
immunogenic  BSA are presumed to remain  (14-16). The immunized animals MARTIN  W.  GRAF  AND  JONATHAN  W.  UH.R  1185 
after removal of antibody, however, still  had considerable antibody  approxi- 
mately 100/~g antibody protein per ml. Thus, serum antibody was in consider- 
able excess. The question arises, therefore, as to how persistent iinmunogen can 
stimulate cells despite the continuous presence of a large excess of antibody. We 
have considered at least three possibilities,  none of which is mutually exclusive 
to explain  this stimulation: (a) The average binding afl~nlty of the postcannu- 
lated serum antibody may have been markedly decreased by a preferential ad- 
sorption of antibody of high binding affinity by the immunoadsorbent, whereas 
the  antibody receptors on the preantibody-forming cells  continue to have a 
high average binding affanity. (b) There may be a gradient between concentra- 
tion of antibody in the serum and the immunogenic site within the lymphoid 
tissue. (c) Stimulation of preantibody secreting cells to proliferate and differen- 
tiate may be irreversible, thus favoring this pathway. We have no information 
at the present time to exclude any of these possibilities. 
Regardless of mechanism, the present studies indicate that serum  antibody 
plays  a  significant  role  in  controlling  the  rate  of  antibody formation  to  a 
metabolizable antigen. 
SUMMARY 
Rabbits  were  injected  intravenously  with  bovine  serum  albumin  (BSA) 
and  bacteriophage T9  (T2). 2-3 wk later,  anti-BSA was removed from such 
animals  by a  procedure which involved exposure of removed plasma  to  an 
immunoadsorbent (12~I-BSA bound to bromoacetyl cellulose) and return of the 
adsorbed plasma to the animal.  This resulted in removal of the majority  of 
antibody activity to BSA without affecting antibody levels to T~. 1-2 days later, 
anfi-BSA levels began to rise, and reached peak levels usually 5 days after the 
removal of antibody. Antibody levels to T~ did not change.  No evidence was 
obtained that BSA was released from the immunoadsorbent into the circulation 
of the rabbits. Thus, only trace amounts of radioactivity were released into the 
plasma;  most  of  the  radioactivity  was  equally  coprecipitable with  BSA  or 
human gamma globulin and their specific antibodies; the released material was 
not demonstrated to be immunogenic in primed rabbits; and the released mate- 
rial did not elute with BSA on gel filtration. The results are interpreted as evi- 
dence that serum antibody acts as a regulatory mechanism for antibody forma- 
tion during the conventional antibody response to a metabolizable antigen. 
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